BTAI vs. OPK

In the year-to-date period, BTAI achieves a -77.94% return, which is significantly lower than OPK's -6.12% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for BioXcel Therapeutics, Inc. (BTAI) and OPKO Health, Inc. (OPK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BTAI Sharpe Ratio is -0.67, which is lower than the OPK Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of BTAI and OPK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BTAI nor OPK has paid dividends to shareholders.

The maximum BTAI drawdown since its inception was -99.89%, roughly equal to the maximum OPK drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for BTAI and OPK.

BioXcel Therapeutics, Inc. (BTAI) has a higher volatility of 20.66% compared to OPKO Health, Inc. (OPK) at 12.80%. This indicates that BTAI's price experiences larger fluctuations and is considered to be riskier than OPK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between BioXcel Therapeutics, Inc. and OPKO Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.